Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis
Clinical trial NCT03389893 · TERMINATED
Trial details
- NCT number
- NCT03389893
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-25
- Primary completion
- 2020-04-03
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.